Pathologic fracture as a complication in the treatment of Ewing's sarcoma

被引:18
|
作者
Fuchs, B [1 ]
Valenzuela, RG [1 ]
Sim, FH [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Orthoped, Div Orthoped Oncol, Rochester, MN 55905 USA
关键词
D O I
10.1097/01.blo.0000093893.12372.9d
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The purpose of the current study was to define the outcome of patients with Ewing's sarcoma who sustained a fracture either at initial presentation or subsequent to multimodal treatment, and to identify parameters that may influence the treatment of these patients. The age of the 21 males and 14 females who sustained a fracture during the treatment for Ewing's sarcoma averaged 15 years (range, 4-30 years) at diagnosis. Fourteen patients presented with a pathologic fracture, whereas 21 patients had a fracture develop subsequent to the initial treatment at a mean of 4 years (range, 1-19 years). The femur was the most common location (50%). At a mean followup of 10 years (range, 1-33 years), 21 of 35 patients (60%) were alive and free of disease. There was no local recurrence, but there was one postradiation sarcoma associated with the fracture. Comparing the followup of patients who sustained the fracture at presentation with the followup of patients who subsequently had a fracture, no statistically significant difference was found (117 months versus 124 months). Overall, pathologic fracture in association with Ewing's sarcoma does not seem to be a negative prognostic parameter with respect to survival in this series. Therefore, a fracture at presentation may not mandate amputation. However, it occurs frequently subsequent to initial multimodal treatment because of delayed fracture healing. Because conservative or minimal osteosynthesis have high failure rates, more aggressive resection and reconstruction have to be considered carefully.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 50 条
  • [1] EWING SARCOMA, ADJUVANT CHEMOTHERAPY AND PATHOLOGIC FRACTURE
    ROSENSTOCK, JG
    JONES, PM
    PEARSON, D
    PALMER, MK
    EUROPEAN JOURNAL OF CANCER, 1978, 14 (07) : 799 - 803
  • [2] Ewing's Sarcoma Mimicking an Avulsion Fracture
    Vanhoenacker, Charlotte
    Myncke, Jan
    Vanhoenacker, Filip
    JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY, 2021, 105 (01):
  • [3] Current treatment for Ewing's sarcoma
    Thacker, MM
    Temple, HT
    Scully, SP
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (02) : 319 - 331
  • [4] Treatment of femoral Ewing's sarcoma
    Terek, RM
    Brien, EW
    Marcove, RC
    MEyers, PA
    Lane, JM
    Healey, JH
    CANCER, 1996, 78 (01) : 70 - 78
  • [5] Diagnosis and treatment of Ewing's sarcoma
    Iwamoto, Yukihide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (02) : 79 - 89
  • [6] Primary Extraosseous Ewing's Sarcoma of the Lung: Radiologic and Pathologic correlation
    Ozturk, Saffet
    Ozturk, Esin Kurtulus
    Ozbulbul, Nilgun Isiksalan
    Acu, Berat
    Dundar, Emine
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [7] Ewing's Sarcoma of the Stomach; Rare Case of Ewing's Sarcoma and Suggestion of New Treatment Strategy
    Kim, Hyo-Sin
    Kim, Sungsoo
    Min, Young-Don
    Kee, Keun-Hong
    Hong, Ran
    JOURNAL OF GASTRIC CANCER, 2012, 12 (04) : 258 - 261
  • [8] Treatment of pelvic Ewing's sarcoma with multidisciplinary treatment
    Delepine, N
    Alkallaf, S
    Sokolov, T
    Cornille, H
    Delepine, G
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 279 - 279
  • [9] Potential approaches to the treatment of Ewing's sarcoma
    Yu, Hongjiu
    Ge, Yonggui
    Guo, Lianying
    Huang, Lin
    ONCOTARGET, 2017, 8 (03) : 5523 - 5539
  • [10] Treatment strategies for metastatic Ewing's sarcoma
    Pinkerton, CR
    Bataillard, A
    Guillo, S
    Oberlin, O
    Fervers, B
    Philip, T
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (11) : 1338 - 1344